Exchange: NYSE·Updated 07:53 PM EDT

CL News

News
all
press releases
Here's Why Colgate-Palmolive (CL) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
More News
Procter & Gamble Fabric & Home Care Trends Mixed: Is Growth Ahead?
PG's Fabric & Home Care shows mixed trends as U.S. Fabric Care improves, Home Care slips and innovation lifts growth in Tide.
Zacks
Is P&G Stock Worth Buying as Growth Slows and Valuation Stays Rich?
PG enters fiscal 2027 with modest growth and a valuation premium, as productivity, innovation and robust cash returns support its investment case.
Zacks
P&G Fiscal 2027 Outlook Brings an 8% Core EPS Headwind Into Focus
PG faces an 8% fiscal 2027 core EPS headwind from higher input costs, financing expense, lower non-operating income and currency pressures.
Zacks
Insider Selling: Panagiotis Tsourapas Unloads $920K Of Colgate-Palmolive Stock
Revealing a significant insider sell on August 26, Panagiotis Tsourapas, COO at Colgate-Palmolive (NYSE:CL), as per the latest SEC filing. What Happened: After conducting a thorough analysis, Tsourapas sold 10,000read more...
Benzinga
Colgate-Palmolive Webcasts Fireside Chat at the Barclays 2026 Global Consumer Staples Conference
Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, will participate in a fireside chat on Wednesday, September 9, 2026 at 8:15 a.m. ET at the Barclays 2026 Global Consumer Staples Conference. Investors may access a live webcast of this fireside chat on Colgates website at...
Business Wire
Colgate Raises 2026 Profit Outlook After Q2 Earnings Beat and Margin Gains
CL raised its 2026 profit outlook after a Q2 earnings beat and 140-basis-point margin gain, while higher costs and North America remain risks.
Zacks
Is Colgate Stock a Buy as Growth Improves but Valuation Stays Rich?
CL enters the second half with better volumes, resilient margins and a higher earnings outlook, but rich valuation and U.S. weakness temper the upside.
Zacks
Colgate-Palmolive Stock Slips Below 50-Day SMA: Time to Be Cautious?
CL slips below its 50-day SMA as U.S. softness, competition and rising costs weigh despite solid Q2 growth and global momentum.
Zacks
CL's Q2 Revenues Rise 4.9%: Can Growth Hold Amid Global Volatility?
Colgate's Q2 revenues rise 4.9% as emerging markets, Europe and Hill's drive growth, but U.S. weakness and rising costs cloud the second-half outlook.
Zacks

Advertisement|Remove ads.